Načítá se...
Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL
The hypothesis that raising high-density lipoprotein cholesterol (HDL-C) levels could improve the risk for cardiovascular disease (CVD) is facing challenges. There is multitudinous clear clinical evidence that the latest failures of HDL-C-raising drugs show no clear association with risks for CVD. A...
Uloženo v:
Hlavní autoři: | , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
MDPI AG
2015-07-01
|
Edice: | International Journal of Molecular Sciences |
Témata: | |
On-line přístup: | http://www.mdpi.com/1422-0067/16/8/17245 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|